Prediction of chromosomal aneuploidy from gene expression data

Genes Chromosomes and Cancer

Volumn 46, Issue 1, 2007, Pages 75-86

  Hertzberg, Libi ^a,b,c   Betts, David R ^d   Raimondi, Susana C ^e   Schäfer, Beat W ^d   Notterman, Daniel A ^f   Domany, Eytan ^c   Izraeli, Shai ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^d UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^e ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^f ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ANEUPLOIDY; ARTICLE; CANCER GENETICS; CHROMOSOME ANALYSIS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC DATABASE; HUMAN; INTERMETHOD COMPARISON; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REFERENCE VALUE; SOLID TUMOR;

ANEUPLOIDY; COLONIC NEOPLASMS; GENE DOSAGE; GENE EXPRESSION PROFILING; HUMANS; MELANOMA; UVEA;

EID: 33751110896     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20391     Document Type: Article

References (33)

1. Albertson DG, Pinkel D. 2003. Genomic microarrays in human genetic disease and cancer. Hum Mol Genet 12:R145-R152.
2. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc 57:289-300.
3. Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM. 1984. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224:1121-1124.
4. Caron H, Schaik BV, Mee MV, Baas F, Riggins G, Sluis PV, Hermus MC, Asperen RV, Boon K, Vote PA, Heisterkamp S, van Kampen A, Versteeg R. 2001. The human transcriptome map: Clustering of highly expressed genes in chromosomal domains. Science 291: 1289-1292.
5. Crawley JJ, Purge KA. 2002. Identification of frequent cytogenetic aberrations in hepatocellular carcinoma using gene-expression microarray data. Genome Biol 3:0075.1-0075.8.
6. Duesberg P, Li R. 2003. Multistep carcinogenesis: A chain reaction of aneuploidizations. Cell Cycle 2:202-210.
7. Georgantas RW III, Tanadve V, Malehorn M, Heimfeld S, Chen C, Carr L, Martinez-Murillo F, Riggins G, Kowalski J, Civin CI. 2004. Microarray and serial analysis of gene expression analyses identify known and novel transcripts overexpressed in hematopoietic stem cells. Cancer Res 64:4434-4441.
8. Golan-Mashiach M, Dazard JE, Gerecht-Nir S, Amariglio N, Fisher T, Jacob-Hirsch J, Bielorai B, Osenberg S, Barad O, Getz G, Toren A, Rechavi G, Itskovitz-Eldor J, Domany E, Givol D. 2005. Design principle of gene expression used by human stem cells: Implication for pluripotency. FASEB J 19:147-149.
9. Hanks S, Coleman K, Reid S, Plaja A, Firth H, Fitzpatrick D, Kidd A, Mehes K, Nash R, Robin N, Shannon N, Tolmie J, Swansbury J, Itrthum A, Douglas J, Rahman N. 2004. Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B. Nat Genet 36:1159-1161.
10. Heerema NA, Sather HN, Sensel MG, Zhang T, Hutchinson RJ, Nachman JB, Lange BJ, Steinherz PG, Bostrom BC, Reaman GH, Gaynon PS, Uckun FM. 2000. Prognostic impact of trisomies of chromosomes 10, 17, and 5 among children with acute lymphoblastic leukemia and high hyperdiploidy (>50 chromosomes). J Clin Oncol 18:1876-1887.
11. Hernando E, Nahle Z, Juan G, Diaz-Rodriguez E, Alaminos M, Hemann M, Michel L, Mittal V, Gerald W, Benezra R, Lowe SW, Cordon-Cardo C. 2004. Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control. Nature 430:797-802.
12. Hughes TR, Roberts CJ, Dai H, Jones AR, Meyer MR, Slade D, Burchard J, Dow S, Ward TR, Kidd MJ, Friend SH, Marton MJ. 2000. Widespread aneuploidy revealed by DNA microarray expression profiling. Nat Genet 25:333-337.
13. Iwamoto M, Banerjee D, Menon LG, Jurkiewicz A, Rao PH, Kemeny NE, Fong Y, Jhanwar SC, Gorlick R, Bertino JR. 2004. Overexpression of E2F-1 in lung and liver metastases of human colon cancer is associated with gene amplification. Cancer Biol Ther 3:395-399.
14. Izraeli S 2005. Perspective: Chromosomal aneuploidy in leukemialessons from Down syndrome. Hematol Oncol 24:3-6.
15. Moorman AV, Richards SM, Martineau M, Cheung KL, Robinson HM, Jalali GR, Broadfield ZJ, Harris RL, Taylor KE, Gibson BE, Hann IM, Hill FG, Kinsey SE, Eden TO, Mitchell CD, Harrison CJ. 2003. Outcome heterogeneity in childhood high-hyperdiploid acute lymphoblastic leukemia. Blood 102:2756-2762.
16. Nigro JM, Misra A, Zhang L, Smirnov I, Colman H, Griffin C, Ozburn N, Chen M, Pan E, Koul D, Yung WK, Feuerstein BG, Aldape KD. 2005. Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma. Cancer Res 65: 1678-1686.
17. Nowak MA, Komarova NL, Sengupta A, Jallepalli PV, Shih Ie M, Vogelstein B, Lengauer C. 2002. The role of chromosomal instability in tumor initiation. Proc Natl Acad Sci USA 99:16226-16231.
18. Phillips JL, Hayward SW, Wang Y, Vasselli J, Pavlovich C, Padilla-Nash H, Pezullo JR, Ghadimi BM, Grossfeld GD, Rivera A, Linehan WM, Cunha GR, Ried T. 2001. The consequences of chromosomal aneuploidy on gene expression profiles in a cell line model for prostate carcinogenesis. Cancer Res 61:8143-8149.
19. Platzer P, Upender MB, Wilson K, Willis J, Lutterbaugh J, Nosrati A, Willson JK, Mack D, Ried T, Markowitz S. 2002. Silence of chromosomal amplifications in colon cancer. Cancer Res 62:1134-1138.
20. Pollack JR, Sorlie T, Perou CM, Rees CA, Jeffrey SS, Lonning PE, Tibshirani R, Botstein D, Borresen-Dale AL, Brown PO. 2002. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc Natl Acad Sci USA 99:12963-12968.
21. Pui CH, Campana D, Evans WE. 2001. Childhood acute lymphoblastic leukaemia-Current status and future perspectives. Lancet Oncol 2:597-607.
22. Ross ME, Zhou X, Song G, Shurtleff SA, Girtman K, Williams WK, Liu HC, Mahfouz R, Raimondi SC, Lenny N, Patel A, Downing JR. 2003. Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. Blood 102:2951-2959.
23. Schoch C, Kohlmann A, Dugas M, Kern W, Hiddemann W, Schnittger S, Haferlach T. 2005. Genomic gains and losses influence expression levels of genes located within the affected regions: A study on acute myeloid leukemias with trisomy 8, 11, or 13, monosomy 7, or deletion 5q. Leukemia 19:1224-1228.
24. Su AI, Cooke MP, Ching KA, Hakak Y, Walker JR, Wiltshire T, Orth AP, Vega RG, Sapinoso LM, Moqrich A, Patapoutian A, Hampton GM, Schultz PG, Hogenesch JB. 2002. Large-scale analysis of the human and mouse transcriptomes. Proc Natl Acad Sci USA 99: 4465-4470.
25. Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D, Zhang J, Soden R, Hayakawa M, Kreiman G, Cooke MP, Walker JR, Hogenesch JB. 2004. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci USA 101:6062-6067.
26. Teixeira MR, Heim S. 2005. Multiple numerical chromosome aberrations in cancer: What are their causes and what are their consequences? Semin Cancer Biol 15:3-12.
27. Tsafrir D, Bacolod M, Selvanayagam Z, Tsafrir I, Shia J, Zeng Z, Liu H, Krier C, Stengel RF, Barany F, Gerald VVL, Paty PB, Domany E, Notterman DA. 2006. Relationship of gene expression and chromosomal abnormalities in colorectal cancer. Cancer Res 66:2129-2137.
28. Tschentscher F, Husing J, Holter T, Kruse E, Dresen IG, Jockel KH, Anastassiou G, Schilling H, Bornfeld N, Horsthemke B, Lohmann DR, Zeschnigk M. 2003. Tumor classification based on gene expression profiling shows that uveal melanomas with and without monosomy 3 represent two distinct entities. Cancer Res 63:2578-2584.
29. Virtaneva K, Wright FA, Tanner SM, Yuan B, Lemon WJ, Caligiuri MA, Bloomfield CD, de La Chapelle A, Krahe R. 2001. Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics. Proc Natl Acad Sci USA 98:1124-1129.
30. Vogelstein B, Kinzler KW. 2004. Cancer genes and the pathways they control. Nat Med 10:789-799.
31. Wang X, Jin DY, Ng RW, Feng H, Wong WC, Cheung AL, Tsao SW. 2004. Significance of MAD2 expression to mitotic checkpoint control in ovarian cancer cells. Cancer Res 62:1662-1668.
32. Yi Y, Mirosevich J, Shyr Y, Matusik R, George AL, Jr. 2005. Coupled analysis of gene expression and chromosomal location. Genomics 85:401-412.
33. Zimonjic D, Brooks MW, Popescu N, Weinberg RA, Hahn WC. 2001. Derivation of human tumor cells in vitro without widespread genomic instability. Cancer Res 61:8838-8844.